leukemia
DESCRIPTION
LEUKEMIA. DR. AYESHA JUNAID MBBS,MCPS,FCPS. Professor of Pathology Consultant Haematology Incharge Blood Transfusion Services-SIH. Leukemia. OBJECTIVES What is leukemia? What is the Pathogenesis of Leukeima? How do we classify leukemia? ( WHO 2008 classification). - PowerPoint PPT PresentationTRANSCRIPT
LEUKEMIA
DR. AYESHA JUNAIDMBBS,MCPS,FCPS.Professor of PathologyConsultant HaematologyIncharge Blood Transfusion Services-SIH
Leukemia
OBJECTIVES
What is leukemia?What is the Pathogenesis of
Leukeima?How do we classify leukemia? (WHO 2008 classification)
Leukemia
OBJECTIVES
What is their clinical presentation?How do we diagnose leukemia in
laboratory?What are the basic principles of management?
Leukemia vs Leukemoid Reaction
Leucocytosis Neutrophilia,Eosinophilia,Lympho
cytes Leucopenia Leukemoid Reaction Leukemia
Leukemia
Myeloid cells Mitotic pool (blast to myelocytes) Maturation pool (ends with the
mature neutrophil) Storage pool (Mature neutrophils
residing in the bone marrow)
LEUKEMIA
Leukemia is a disease resulting from the neoplastic proliferation of hemopoeitic or lymphoid cells
LEUKEMIA
It results from the mutation in a single stem cell
The progeny of which form a clone of leukemic cells
LEUKEMIA
Genetic events contributing to malignant transformation include
Inappropriate expression of oncogenes
Loss of function of TSG
LEUKEMIA CLASSIFICATION
LINEAGE & DEGREE OF MATURATION
MORPHOLOGYCYTOCHEMICALCYTOGENETICSIMMUNOPHENOTYPICALIMMUNOHISTOCHEMISTRYMOLECULAR GENETICS
LEUKEMIA CLASSIFICATION
WHO 2008 Evidence based classification for daily
therapeutic decisions.
Provides a flexible framework for integration of new data
LEUKEMIA
Acute leukemia Chronic leukemia
Acute Myeloid Leukemia Acute Lymphoid Leukemia Chronic Myeloid Leukemia Chronic Lymphoid Leukemia
ACUTE LEUKEMIA
Heterogeneous group of clonal disorders arising from
• Pluripotent stem cells• Clinical course• Response to therapy
ACUTE LEUKEMIA
Acute leukemia accounts for approximately 10% of all human cancers
Is the leading cause of cancer deaths in adults younger than 35 years of age
BONE MARROW TREPHINE HIGH AND LOW POWER
CYTOCHEMISTRY It identifies diagnostically useful enzymes
or other cytoplasmic substances of hemopoietic cells
Particularly useful for identification of immature cells in leukemia
SUDAN BLACK B PERIODIC ACID SCHIFF(PAS) ACID PHOSPHATASE
Leukemia
AML/ALL MORPHOLOGY Differentiation on morphological grounds
alone is not possible
Morphological features favoring lymphoid derivation include
Blasts including relatively condensed chromatin
Absence of conspicuous nucleoli Presence of scanty agranular cytoplasm
CYTOCHEMISTRY
CYTOCHEMISTRY
PAS
ACUTE LEUKEMIAAMLALL
ACUTE LEUKEMIA
CLINICAL FEATURESONSET Abrupt, acute Insidious, slowly progressive Bone marrow malfunction Anemia, infection & bleeding
ACUTE LYMPHOBLASTIC LEUKEMIA
CLINICAL FEATURES Bone pain & tenderness Lymphadenopathy Splenomegaly Hepatomegally CNS manifestations Testicular involvement Skin
LEUKEMIA
LABORATORY EVALUATION
Anemia Leukocytosis/leukopenia/normal
TLC Thrombocytopenia Bone marrow examination Aspirate & biopsy
LABORATORY EVALUATION
LEUKEMIA